ABOUT THIS EPISODE
In this episode, host Ann-Marie delves into the complexities of Atrial Fibrillation (AF) with Dr. Robert Rose, a scientist and professor in the departments of Cardiac Sciences, Physiology and Pharmacology at the Cumming School of Medicine, Libin Cardiovascular Institute at the University of Calgary.
Unpacking the intricacies of cardiovascular disease, the Robert Rose Laboratory conducts cutting-edge research, and among many areas of focus, seeks to unravel the elusive causes of AF, a widespread cardiac condition that remains not fully understood. This discussion illuminates the promising role of the natriuretic peptide receptor B (NPR-B), a receptor in the heart, in regulating and sustaining normal heart rhythm. Impaired activity of the NPR-B is associated with a greater risk of developing AF. These findings could lead to the creation of new preventative treatments for AF in the form of NPR-B agonists.
Dr. Rose shares his enthusiasm for the innovative advancements in cardiac research and his hopeful perspective on future therapeutic strategies to prevent and manage arrhythmias and design patient-specific or condition-specific treatment approaches.
Click here to read the full study discussed in the episode.
For more information on the NPR-B research coming out of the Robert Rose Laboratory, click here.
